is semaglutide hard on your kidneys Semaglutide just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Acute Kidney Injury Associated With

[9] Clinical trials have consistently demonstrated that gastrointestinal adverse effects are the most frequent side effects associated with tirzepatide therapy

Many GLP-1 medications can remain at room temperature for a limited period, often up to 28 days, depending on the specific product and manufacturer instructions

Additional benefits: It contains antioxidants that protect skin cells

A recent 2025 study of more than 6,000 psoriasis patients with diabetes or obesity over a 2-year period, including 3,048 who were treated with GLP-1RAs and 3,048 who received other anti-diabetic or anti-obesity drugs, found that psoriasis patients treated with GLP-1RAs had a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications